Translate

Thursday, 23 January 2014

Complications After Arthroscopic Knee Surgery

Background: Knee arthroscopies are among the most common procedures performed by orthopaedic surgeons, yet little is known about the associated complications and complication rates. 

Purpose: To examine the nature and frequency of complications after the most common arthroscopic knee procedures, with particular attention to fellowship training, geographic location of practice, and age and sex of the patient. 

Study Design: Cross-sectional study; Level of evidence, 3. 

Methods: Data were obtained from the American Board of Orthopaedic Surgery database for orthopaedic surgeons who sat for the part II examination from 2003 to 2009. The database was queried to determine the type and frequency of complications for patients who underwent knee arthroscopy and for those who underwent sports medicine knee arthroscopy, including arthroscopic partial meniscectomy, meniscal repair, chondroplasty, microfracture, anterior cruciate ligament reconstruction, or posterior cruciate ligament reconstruction. Factors affecting complication rates that were investigated included type of procedure, fellowship training status, geographic location of practice, and age and sex of the patient. 

Results: There were 4305 complications out of 92,565 knee arthroscopic procedures obtained from the American Board of Orthopaedic Surgery database for an overall candidate-reported complication rate of 4.7%. The complication rates were highest for posterior cruciate ligament reconstruction (20.1%) and anterior cruciate ligament reconstruction (9.0%); complication rates for meniscectomy, meniscal repair, and chondroplasty were 2.8%, 7.6%, and 3.6%, respectively. The complication rate for sports fellowship–trained candidates was higher than for non–sports trained candidates (5.1% sports, 4.1% no sports; P < .0001) and for male patients (4.9% male vs 4.3% female; P < .0001). Younger patients (<40 years; 6.2%) had a higher complication rate than older patients (≥40 years; 3.58%) (P < .0001). Procedure complexity is a likely confounding factor affecting sports-trained candidates and younger patients. There were no geographic differences (P = .125). The overall rate of pulmonary embolus was 0.11%. Surgical complications (3.68%) were more common than medical (0.77%) or anesthetic complications (0.22%), and infection was the most common complication overall (0.84%). 

Conclusion: The overall self-reported complication rate for arthroscopic knee procedures was 4.7%. Knee arthroscopy is thought not to be a benign procedure, and patients should be made aware of the risk of complications. 


Comment:
Please note that the article reflects the figures for fellowship trainees. They may be different in the group of a specialised surgeon. However, the range of complications and their proportions may be the same.

  

Friday, 10 January 2014

"Red flags" under fire

Most clinical practice guidelines for back pain recommend the use of red flags to help identify those patients with a higher likelihood of spinal fracture or malignancy who then become candidates for more extensive diagnostic investigations. There is confusion, however, as the guidelines have produced different lists of red flags to screen for spinal fracture and malignancy. Eight of the guidelines investigated by Koes and colleagues in their review of back pain guidelines, endorsed 26 red flags for fracture and 27 for malignancy. 

None of the eight guidelines endorsed the same set of red flags, for either condition, so it is unclear what clinicians should use in clinical care. Additionally, guidelines generally provide no information on diagnostic accuracy of the endorsed red flags, which limits their value in clinical decision making. Adding to the uncertainty, the same agency can provide inconsistent information on red flags. For example, the National Institute for Health and Care Excellence clinical guideline on the early management of persistent non-specific low back pain does not endorse red flags, whereas the group’s clinical knowledge summary for the management of low back pain does
To resolve the uncertainty around application of red flags in clinical practice, the authors conducted two Cochrane diagnostic test accuracy reviews assessing the accuracy of red flags to screen for the most common forms of serious pathology—spinal fracture and malignancy—in patients with low back pain. They have provided a distilled summary of both reviews to help guide clinical decision making.

Objective To review the evidence on diagnostic accuracy of red flag signs and symptoms to screen for fracture or malignancy in patients presenting with low back pain to primary, secondary, or tertiary care.

Design Systematic review.

Data sources Medline, OldMedline, Embase, and CINAHL from earliest available up to 1 October 2013.

Inclusion criteria Primary diagnostic studies comparing red flags for fracture or malignancy to an acceptable reference standard, published in any language.

Review methods Assessment of study quality and extraction of data was conducted by three independent assessors. Diagnostic accuracy statistics and post-test probabilities were generated for each red flag.

Results We included 14 studies (eight from primary care, two from secondary care, four from tertiary care) evaluating 53 red flags; only five studies evaluated combinations of red flags. Pooling of data was not possible because of index test heterogeneity. Many red flags in current guidelines provide virtually no change in probability of fracture or malignancy or have untested diagnostic accuracy. The red flags with the highest post-test probability for detection of fracture were older age (9%, 95% confidence interval 3% to 25%), prolonged use of corticosteroid drugs (33%, 10% to 67%), severe trauma (11%, 8% to 16%), and presence of a contusion or abrasion (62%, 49% to 74%). Probability of spinal fracture was higher when multiple red flags were present (90%, 34% to 99%). The red flag with the highest post-test probability for detection of spinal malignancy was history of malignancy (33%, 22% to 46%).

Conclusions While several red flags are endorsed in guidelines to screen for fracture or malignancy, only a small subset of these have evidence that they are indeed informative. These findings suggest a need for revision of many current guidelines.


Read the article:
BMJ 2013;347:f7095 BMJ 2013; 347 doi: http://dx.doi.org/10.1136/bmj.f7095 (Published 11 December 2013). 

Friday, 3 January 2014

Excise or save: Do we need a fat pad?


The infrapatellar fat pad is one of the structures that obscures exposure in minimally invasive total knee arthroplasty (MIS TKA). Most MIS TKA surgeons (and many surgeons who use other approaches as well) excise the fat pad for better exposure of the knee. There is still controversy about the result of fat pad excision on patella baja, pain, and function.

QUESTIONS/PURPOSES:
In the setting of a randomized controlled trial, we sought to determine whether infrapatellar fat pad excision during MIS TKA causes (1) patellar tendon shortening (as measured by patella baja); (2) increased anterior knee pain; (3) decreases in the Knee Society Score or functional subscore; or (4) more patella-related complications.

METHODS:
We randomized 90 patients undergoing MIS TKA at one institution into two groups. In one group, 45 patients underwent MIS TKA with complete infrapatellar fat pad excision and in the other group, 45 patients received MIS TKA without infrapatellar fat pad excision. The patella was selectively resurfaced in these patients; there was no difference between the groups in terms of the percentage of patients whose patellae were resurfaced. We measured patellar tendon shortening, knee flexion, anterior knee pain, Knee Society Score (KSS), functional subscore, and patellar complications at preoperative and postoperative periods of 6 weeks, 3 months, 6 months, and 1 year; complete followup data were available on 86% of patients (77 of 90) who were enrolled.

RESULTS:
At the final followup, no significant differences were observed in patellar tendon shortening, KSS, functional subscore, or knee flexion in either group. However, patients with their infrapatellar fat pad excised experienced more anterior knee pain (8.3% versus 0%; p = 0.03; 95% confidence interval, -0.007 to 0.174) at the end of the study. No patellar complications were found in either group.

CONCLUSIONS:
Infrapatellar fat pad excision in MIS TKA resulted in an increasing small percentage of patients with anterior knee pain after surgery. Surgeons should keep the fat pad if excellent exposure can be achieved but resect it if needed to improve exposure during TKA.

LEVEL I OF EVIDENCE:


 Pinsornsak P, Naratrikun K, Chumchuen S:The Effect of Infrapatellar Fat Pad Excision on Complications After Minimally Invasive TKA: A Randomized Controlled Trial. Clin Orthop Relat Res. 2013 Oct 18.

Thursday, 12 December 2013

Mortality rates at 10 years after metal-on-metal hip resurfacing compared with total hip replacement in England: retrospective cohort analysis of hospital episode statistics

Objectives To compare 10 year mortality rates among patients undergoing metal-on-metal hip resurfacing and total hip replacement in England.
Design Retrospective cohort study.
Setting English hospital episode statistics database linked to mortality records from the Office for National Statistics.

Population All adults who underwent primary elective hip replacement for osteoarthritis from April 1999 to March 2012. The exposure of interest was prosthesis type: cemented total hip replacement, uncemented total hip replacement, and metal-on-metal hip resurfacing. Confounding variables included age, sex, Charlson comorbidity index, rurality, area deprivation, surgical volume, and year of operation.

Main outcome measures All cause mortality. Propensity score matching was used to minimise confounding by indication. Kaplan-Meier plots estimated the probability of survival up to 10 years after surgery. Multilevel Cox regression modelling, stratified on matched sets, described the association between prosthesis type and time to death, accounting for variation across hospital trusts.

Results 7437 patients undergoing metal-on-metal hip resurfacing were matched to 22 311 undergoing cemented total hip replacement; 8101 patients undergoing metal-on-metal hip resurfacing were matched to 24 303 undergoing uncemented total hip replacement. 10 year rates of cumulative mortality were 271 (3.6%) for metal-on-metal hip resurfacing versus 1363 (6.1%) for cemented total hip replacement, and 239 (3.0%) for metal-on-metal hip resurfacing versus 999 (4.1%) for uncemented total hip replacement. Patients undergoing metal-on-metal hip resurfacing had an increased survival probability (hazard ratio 0.51 (95% confidence interval 0.45 to 0.59) for cemented hip replacement; 0.55 (0.47 to 0.65) for uncemented hip replacement). There was no evidence for an interaction with age or sex.

Conclusions Patients with hip osteoarthritis undergoing metal-on-metal hip resurfacing have reduced mortality in the long term compared with those undergoing cemented or uncemented total hip replacement. This difference persisted after extensive adjustment for confounding factors available in our data. The study results can be applied to matched populations, which exclude patients who are very old and have had complex total hip replacements. Although residual confounding is possible, the observed effect size is large. These findings require validation in external cohorts and randomised clinical trials.

 BMJ 2013;347:f6549
 http://www.bmj.com/content/347/bmj.f6549

Wednesday, 30 October 2013

Post-traumatic ulna plus variance associated with poor outcomes for distal radius fractures

Post-traumatic ulna plus variance associated with poor outcomes for distal radius fractures


Researchers in this study found that post-traumatic ulna plus variance greater than 2 mm was the only factor significantly associated with poor outcome when analyzing a cohort of young patients with unilateral distal radius fractures who were not yet at risk for osteoporosis.

“The present study showed that post-traumatic ulna [plus variance] is the most important factor in predicting bad outcome in non-osteoporotic patients, but that especially intra-articular fractures and to a lesser extent dorsal tilt may be of importance too,” the researchers wrote in the study abstract.

The researchers evaluated pre-reduction anteroposterior and lateral wrist radiographs from 66 patients with a median age of 42 years, according to the abstract. They measured fracture pattern, radial length, inclination, joint surface tilt, ulnar variance and measured outcomes using the Gartland and Werley score.

Although not statistically significant, the researchers noted that intra-articular fracture pattern may also be a strong marker for a poor outcome.



Beumer A. BMC Musculoskelet Disord. 2013. doi:10.1186/1471-2474-14-170.

Friday, 18 October 2013

Distal Radius Fractures: Is the use of locking plates justified?

Surgical Treatment of Distal Radial Fractures with a Volar Locking Plate Versus Conventional Percutaneous Methods: A Randomized Controlled Trial


Background:  The aim of this study was to compare the outcomes of displaced distal radial fractures treated with a volar locking plate with the results of such fractures treated with a conventional method of closed reduction and percutaneous wire fixation with supplemental bridging external fixation when required. Our aim was to ascertain whether the use of a volar locking plate improves functional outcomes.

Methods:  A single-center, pragmatic, randomized controlled trial was conducted in a tertiary care institution. One hundred and thirty patients (eighteen to seventy-three years of age) who had a displaced distal radial fracture were randomized to treatment with either a volar locking plate (n = 66) or a conventional percutaneous fixation method (n = 64). Outcome assessments were conducted at six weeks, twelve weeks, and one year. Outcomes were measured on the basis of scores on the Patient Evaluation Measure (PEM) and QuickDASH questionnaire (a shortened version of the Disabilities of the Arm, Shoulder and Hand, or DASH, Outcome Measure), EuroQol-5D (EQ-5D) scores, wrist range of motion, grip strength, and radiographic parameters.

Results:  The rate of follow-up at one year was 95%. Patients in the volar locking-plate group had significantly better PEM and QuickDASH scores and range of motion at six weeks compared with patients in the conventional-treatment group, but there were no significant differences between the two groups at twelve weeks or one year. Grip strength was better in the plate group at all time points. The volar locking plate was better at restoring palmar tilt and radial height. Significantly more patients in the plate group were driving at the end of six weeks, but this did not translate to a significant difference between groups in terms of those returning to work by that time.

Conclusions:  Use of a volar locking plate resulted in a faster early recovery of function compared with use of conventional methods. However, no functional advantage was demonstrated at or beyond twelve weeks. Use of the volar locking plate resulted in better anatomical reduction and grip strength, but there was no significant difference in function between the groups at twelve weeks or one year. The earlier recovery of function may be of advantage to some patients.


Karantana A et al. Surgical Treatment of Distal Radial Fractures with a Volar Locking Plate Versus Conventional Percutaneous Methods. J Bone Joint Surg Am 2013; 95: 1737–44; doi: 10.2106/JBJS.L.00232

Tuesday, 1 October 2013

More myths busted: Copper and magnet therapy are useless in rheumatoid arthritis

Folklore remedies for pain and inflammation in rheumatoid arthritis include the application of magnets and copper to the skin. Despite the popular use of devices containing magnets or copper for this purpose, little research has been conducted to evaluate the efficacy of such treatments.

Objective

To investigate whether the practice of wearing magnetic wrists straps, or copper bracelets, offers any specific therapeutic benefit for patients with rheumatoid arthritis.

Design

Randomised double-blind placebo-controlled crossover trial.

Methods

70 patients, aged 33 to 79 years and predominantly female (n = 52), with painful rheumatoid arthritis were recruited from general practices within Yorkshire. Participants were randomly allocated to wear four devices in a different order. Devices tested were: a standard (1502 to 2365 gauss) magnetic wrist strap, a demagnetised (<20 gauss) wrist strap, an attenuated (250 to 350 gauss) magnetic wrist strap, and a copper bracelet. Devices were each worn for five weeks, with treatment phases being separated by one week wash-out periods. The primary outcome measured was pain using a 100 mm visual analogue scale. Secondary pain measures were the McGill Pain Questionnaire and tender joint count. Inflammation was assessed using C-reactive protein and plasma viscosity blood tests and by swollen joint count. Physical function was assessed using the Health Assessment Questionnaire (Disability Index). Disease activity and medication use was also measured.

Results

65 participants provided complete self-report outcome data for all devices, four participants provided partial data. Analysis of treatment outcomes did not reveal any statistically significant differences (P>0.05) between the four devices in terms of their effects on pain, inflammation, physical function, disease activity, or medication use.

Principal findings

The results of this trial indicate that participants with rheumatoid arthritis obtained little if any specific therapeutic benefit from magnet therapy, involving the use of a 2200 gauss magnetic wrist strap for just over one month. The experimental wrist strap, which was typical of other commonly available devices as regards its magnetic properties and method of application, did not appear to outperform: (a) a very weak (300 gauss) magnetic wrist strap; (b) a non-magnetic wrist strap; or (c) a copper bracelet. Whilst estimated 95% confidence intervals for the individual comparison of experimental and control devices indicate that use of the standard magnetic wrist strap may have resulted in a modest reduction in pain, equivalent to 12 mm on a 100 mm pain VAS, they also indicate the possibility that use of this device may have resulted in a slight increase in pain. Despite such uncertainty, these differences may be viewed as small in terms of potential clinical relevance, and further results obtained for secondary pain measures failed to indicate any analgesic benefit whatsoever resulting from magnet therapy. No overall statistically significant differences were found between experimental and control devices for the primary pain outcome measure (i.e. pain VAS), the McGill Pain Questionnaire, self-assessed measures of tender and swollen joints, disease activity status, physical function, feelings of helplessness, or for two different blood tests used for monitoring levels of acute phase reactants as indicators of bodily inflammation, even when controlling for medication use, local rather than systemic inflammation, and non-compliance. Similarly, we did not observe any evidence, of statistical significance or likely clinical importance, to suggest superiority of the copper bracelet over other control devices.

Conclusions

Wearing a magnetic wrist strap or a copper bracelet did not appear to have any meaningful therapeutic effect, beyond that of a placebo, for alleviating symptoms and combating disease activity in rheumatoid arthritis.